Specify a stock or a cryptocurrency in the search bar to get a summary
Guard Therapeutics International AB
GUARDGuard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden. Address: Nybrogatan 34, 2 tr, Stockholm, Sweden, 114 39
Analytics
WallStreet Target Price
706.34 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures GUARD
Dividend Analytics GUARD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GUARD
Stock Valuation GUARD
Financials GUARD
Results | 2019 | Dynamics |